Article Details
Retrieved on: 2021-08-11 15:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
As AstraZeneca and FibroGen explore the next steps for anemia drug roxadustat after an FDA complete response letter, the focus of the med is shifting ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here